世界の肺がん手術市場は、2024年に約62億7,000万米ドルと評価され、2025〜2035年の予測期間にわたって3.80%以上の安定した年平均成長率（CAGR）で成長すると見込まれています。肺悪性腫瘍治療の要となる肺がん手術には、外科医ががん組織を効果的に除去し、肺機能を温存し、患者の転帰を改善することを可能にする、幅広い高度な外科的処置とデバイスが含まれます。喫煙、大気汚染、職業上の危険、遺伝的素因によって引き起こされる肺がんの世界的な負担の増加に伴い、外科的介入の需要は急増し続けています。低侵襲手術（MIS）技術の採用増加と高度なモニタリングおよび内視鏡デバイスの統合により、外科的介入の状況はさらに変化し、医療提供者はより安全で迅速かつ効率的な手術を提供できるようになりました。
肺がんの罹患率の急速な増加により、外科手術の必要性が大幅に高まり、特殊な器具や高度な技術に対する需要が高まっています。世界保健機関（WHO）によると、肺がんは依然として世界的にがん関連死亡の主な原因であり、年間約180万人が亡くなっています。ロボット支援胸部手術、胸腔鏡手術（VATS）、精密駆動型手術器具などの技術進歩は、手術成績の向上と術後合併症の減少の機会を生み出しています。さらに、早期発見プログラムへの重点化とがん治療インフラの改善に向けた政府の取り組みが、市場拡大の原動力となることが期待されています。しかしながら、高額な手術費用、発展途上地域における高度な医療施設へのアクセスの制限、代替療法の採用増加などが、予測期間中の市場成長を阻害する可能性があります。
地域別では、北アメリカが2025年の世界の肺がん手術市場で最大のシェアを占めました。これは、高度な医療インフラ、主要医療機器メーカーの強力なプレゼンス、肺がん症例の高い有病率、そして最先端の外科技術の急速な導入によるものです。ヨーロッパもまた、有利な保険償還政策、高度ながん検診プログラム、そして外科的治療選択肢に対する意識の高まりに牽引され、重要な市場となっています。一方、アジア太平洋地域は、喫煙率の上昇、急速な都市化、そして中国やインドなどの人口密集国における大気汚染の増加による肺がん発症率の急増を背景に、予測期間中に最も急速な成長が見込まれています。医療投資の拡大、低侵襲手術への需要の高まり、そして熟練した胸部外科医の確保は、この地域の成長ポテンシャルをさらに高めています。ラテンアメリカと中東・アフリカも、医療アクセスの改善とがん治療への政府支出の増加に支えられ、着実な成長が見込まれています。
本調査の目的は、近年における様々なセグメントおよび国における市場規模を定義し、今後数年間の価値を予測することです。本レポートは、調査対象国における業界の定性的および定量的側面の両方を網羅するように設計されており、市場の将来の成長を決定づける推進要因や課題といった重要な側面についても詳細な情報を提供しています。さらに、利害関係者が投資できるマイクロ市場における潜在的な機会、そして主要プレーヤーの競争環境と製品提供の詳細な分析も盛り込んでいます。
目次
Table of Content
Chapter 1. Global Lung Cancer Surgery Market Report Scope & Methodology
1.1. Research Objective
1.2. Research Methodology
1.2.1. Forecast Model
1.2.2. Desk Research
1.2.3. Top Down and Bottom-Up Approach
1.3. Research Attributes
1.4. Scope of the Study
1.4.1. Market Definition
1.4.2. Market Segmentation
1.5. Research Assumption
1.5.1. Inclusion & Exclusion
1.5.2. Limitations
1.5.3. Years Considered for the Study
Chapter 2. Executive Summary
2.1. CEO/CXO Standpoint
2.2. Strategic Insights
2.3. ESG Analysis
2.4. Key Findings
Chapter 3. Global Lung Cancer Surgery Market Forces Analysis
3.1. Market Forces Shaping The Global Lung Cancer Surgery Market (2024-2035)
3.2. Drivers
3.2.1. Rising lung cancer incidence and expansion of LDCT screening programs increasing surgical candidacy
3.2.2. Adoption of minimally invasive and robotic-assisted thoracic surgery improving outcomes and throughput
3.3. Restraints
3.3.1. High procedure and device costs with limited access to advanced surgical infrastructure in developing regions
3.3.2. Shift toward targeted and immuno-oncology therapies reducing surgical volumes in select patient cohorts
3.4. Opportunities
3.4.1. Technological innovation (AI-guided imaging, 3D planning, patient-specific instruments, ERAS protocols)
3.4.2. APAC capacity build-out amid urbanization and pollution burden, creating new demand pockets
Chapter 4. Global Lung Cancer Surgery Industry Analysis
4.1. Porter’s 5 Forces Model
4.1.1. Bargaining Power of Buyer
4.1.2. Bargaining Power of Supplier
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Forecast Model (2024-2035)
4.3. PESTEL Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top Investment Opportunities
4.5. Top Winning Strategies (2025)
4.6. Market Share Analysis (2024-2025)
4.7. Global Pricing Analysis And Trends 2025
4.8. Analyst Recommendation & Conclusion
Chapter 5. Global Lung Cancer Surgery Market Size & Forecasts by Instrument 2025-2035
5.1. Market Overview
5.2. Global Lung Cancer Surgery Market Performance - Potential Analysis (2025)
5.3. Clamps
5.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
5.3.2. Market size analysis, by region, 2025-2035
5.4. Forceps
5.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
5.4.2. Market size analysis, by region, 2025-2035
5.5. Trocars
5.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
5.5.2. Market size analysis, by region, 2025-2035
5.6. Retractors
5.6.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
5.6.2. Market size analysis, by region, 2025-2035
5.7. Scissors
5.7.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
5.7.2. Market size analysis, by region, 2025-2035
5.8. Monitoring & Endoscopic Devices
5.8.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
5.8.2. Market size analysis, by region, 2025-2035
Chapter 6. Global Lung Cancer Surgery Market Size & Forecasts by Procedure 2025-2035
6.1. Market Overview
6.2. Global Lung Cancer Surgery Market Performance - Potential Analysis (2025)
6.3. Thoracotomy
6.3.1. Lobectomy
6.3.1.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
6.3.1.2. Market size analysis, by region, 2025-2035
6.3.2. Pneumonectomy
6.3.2.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
6.3.2.2. Market size analysis, by region, 2025-2035
6.3.3. Segmentectomy
6.3.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
6.3.3.2. Market size analysis, by region, 2025-2035
6.3.4. Sleeve Resection
6.3.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
6.3.4.2. Market size analysis, by region, 2025-2035
6.4. Minimally Invasive Surgery (MIS)
6.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
6.4.2. Market size analysis, by region, 2025-2035
Chapter 7. Global Lung Cancer Surgery Market Size & Forecasts by Region 2025-2035
7.1. Lung Cancer Surgery Market, Regional Market Snapshot
7.2. Top Leading & Emerging Countries
7.3. North America Lung Cancer Surgery Market
7.3.1. U.S. Lung Cancer Surgery Market
7.3.1.1. Instrument breakdown size & forecasts, 2025-2035
7.3.1.2. Procedure breakdown size & forecasts, 2025-2035
7.3.2. Canada Lung Cancer Surgery Market
7.3.2.1. Instrument breakdown size & forecasts, 2025-2035
7.3.2.2. Procedure breakdown size & forecasts, 2025-2035
7.4. Europe Lung Cancer Surgery Market
7.4.1. UK Lung Cancer Surgery Market
7.4.1.1. Instrument breakdown size & forecasts, 2025-2035
7.4.1.2. Procedure breakdown size & forecasts, 2025-2035
7.4.2. Germany Lung Cancer Surgery Market
7.4.2.1. Instrument breakdown size & forecasts, 2025-2035
7.4.2.2. Procedure breakdown size & forecasts, 2025-2035
7.4.3. France Lung Cancer Surgery Market
7.4.3.1. Instrument breakdown size & forecasts, 2025-2035
7.4.3.2. Procedure breakdown size & forecasts, 2025-2035
7.4.4. Spain Lung Cancer Surgery Market
7.4.4.1. Instrument breakdown size & forecasts, 2025-2035
7.4.4.2. Procedure breakdown size & forecasts, 2025-2035
7.4.5. Italy Lung Cancer Surgery Market
7.4.5.1. Instrument breakdown size & forecasts, 2025-2035
7.4.5.2. Procedure breakdown size & forecasts, 2025-2035
7.4.6. Rest of Europe Lung Cancer Surgery Market
7.4.6.1. Instrument breakdown size & forecasts, 2025-2035
7.4.6.2. Procedure breakdown size & forecasts, 2025-2035
7.5. Asia Pacific Lung Cancer Surgery Market
7.5.1. China Lung Cancer Surgery Market
7.5.1.1. Instrument breakdown size & forecasts, 2025-2035
7.5.1.2. Procedure breakdown size & forecasts, 2025-2035
7.5.2. India Lung Cancer Surgery Market
7.5.2.1. Instrument breakdown size & forecasts, 2025-2035
7.5.2.2. Procedure breakdown size & forecasts, 2025-2035
7.5.3. Japan Lung Cancer Surgery Market
7.5.3.1. Instrument breakdown size & forecasts, 2025-2035
7.5.3.2. Procedure breakdown size & forecasts, 2025-2035
7.5.4. Australia Lung Cancer Surgery Market
7.5.4.1. Instrument breakdown size & forecasts, 2025-2035
7.5.4.2. Procedure breakdown size & forecasts, 2025-2035
7.5.5. South Korea Lung Cancer Surgery Market
7.5.5.1. Instrument breakdown size & forecasts, 2025-2035
7.5.5.2. Procedure breakdown size & forecasts, 2025-2035
7.5.6. Rest of APAC Lung Cancer Surgery Market
7.5.6.1. Instrument breakdown size & forecasts, 2025-2035
7.5.6.2. Procedure breakdown size & forecasts, 2025-2035
7.6. Latin America Lung Cancer Surgery Market
7.6.1. Brazil Lung Cancer Surgery Market
7.6.1.1. Instrument breakdown size & forecasts, 2025-2035
7.6.1.2. Procedure breakdown size & forecasts, 2025-2035
7.6.2. Mexico Lung Cancer Surgery Market
7.6.2.1. Instrument breakdown size & forecasts, 2025-2035
7.6.2.2. Procedure breakdown size & forecasts, 2025-2035
7.7. Middle East and Africa Lung Cancer Surgery Market
7.7.1. UAE Lung Cancer Surgery Market
7.7.1.1. Instrument breakdown size & forecasts, 2025-2035
7.7.1.2. Procedure breakdown size & forecasts, 2025-2035
7.7.2. Saudi Arabia (KSA) Lung Cancer Surgery Market
7.7.2.1. Instrument breakdown size & forecasts, 2025-2035
7.7.2.2. Procedure breakdown size & forecasts, 2025-2035
7.7.3. South Africa Lung Cancer Surgery Market
7.7.3.1. Instrument breakdown size & forecasts, 2025-2035
7.7.3.2. Procedure breakdown size & forecasts, 2025-2035
Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Medtronic plc
8.2.1. Company Overview
8.2.2. Key Executives
8.2.3. Company Snapshot
8.2.4. Financial Performance (Subject to Data Availability)
8.2.5. Product/Services Port
8.2.6. Recent Development
8.2.7. Market Strategies
8.2.8. SWOT Analysis
8.3. Johnson & Johnson (Ethicon, Inc.)
8.4. Olympus Corporation
8.5. Siemens Healthineers AG
8.6. Intuitive Surgical, Inc.
8.7. Boston Scientific Corporation
8.8. Zimmer Biomet Holdings, Inc.
8.9. Stryker Corporation
8.10. Smith & Nephew plc
8.11. B. Braun Melsungen AG
8.12. KARL STORZ SE & Co. KG
8.13. Fujifilm Holdings Corporation
8.14. Accuray Incorporated
8.15. CONMED Corporation
8.16. Terumo Corporation
List of Tables
Table 1. Global Lung Cancer Surgery Market, Report Scope
Table 2. Global Lung Cancer Surgery Market Estimates & Forecasts By Region 2024-2035
Table 3. Global Lung Cancer Surgery Market Estimates & Forecasts By Instrument 2024-2035
Table 4. Global Lung Cancer Surgery Market Estimates & Forecasts By Procedure 2024-2035
Table 5. Clamps Market Estimates & Forecasts, 2024-2035
Table 6. Forceps Market Estimates & Forecasts, 2024-2035
Table 7. Monitoring & Endoscopic Devices Market Estimates & Forecasts, 2024-2035
Table 8. U.S. Lung Cancer Surgery Market Estimates & Forecasts, 2024-2035
Table 9. Canada Lung Cancer Surgery Market Estimates & Forecasts, 2024-2035
Table 10. UK Lung Cancer Surgery Market Estimates & Forecasts, 2024-2035
Table 11. Germany Lung Cancer Surgery Market Estimates & Forecasts, 2024-2035
Table 12. France Lung Cancer Surgery Market Estimates & Forecasts, 2024-2035
Table 13. Spain Lung Cancer Surgery Market Estimates & Forecasts, 2024-2035
Table 14. Italy Lung Cancer Surgery Market Estimates & Forecasts, 2024-2035
Table 15. Rest Of Europe Lung Cancer Surgery Market Estimates & Forecasts, 2024-2035
Table 16. China Lung Cancer Surgery Market Estimates & Forecasts, 2024-2035
Table 17. India Lung Cancer Surgery Market Estimates & Forecasts, 2024-2035
Table 18. Japan Lung Cancer Surgery Market Estimates & Forecasts, 2024-2035
Table 19. Australia Lung Cancer Surgery Market Estimates & Forecasts, 2024-2035
Table 20. South Korea Lung Cancer Surgery Market Estimates & Forecasts, 2024-2035
………….
List of Figures
Fig 1. Global Lung Cancer Surgery Market, Research Methodology
Fig 2. Global Lung Cancer Surgery Market, Market Estimation Techniques
Fig 3. Global Market Size Estimates & Forecast Methods
Fig 4. Global Lung Cancer Surgery Market, Key Trends 2025
Fig 5. Global Lung Cancer Surgery Market, Growth Prospects 2024-2035
Fig 6. Global Lung Cancer Surgery Market, Porter’s Five Forces Model
Fig 7. Global Lung Cancer Surgery Market, PESTEL Analysis
Fig 8. Global Lung Cancer Surgery Market, Value Chain Analysis
Fig 9. Lung Cancer Surgery Market By Instrument, 2025 & 2035
Fig 10. Lung Cancer Surgery Market By Procedure, 2025 & 2035
Fig 11. Thoracotomy Subtype Share (Lobectomy, Pneumonectomy, Segmentectomy, Sleeve Resection), 2025 & 2035
Fig 12. Instrument Category Share (Clamps, Forceps, Trocars, Retractors, Scissors), 2025 & 2035
Fig 13. Monitoring & Endoscopic Devices Share within Instruments, 2025 & 2035
Fig 14. North America Lung Cancer Surgery Market, 2025 & 2035
Fig 15. Europe Lung Cancer Surgery Market, 2025 & 2035
Fig 16. Asia Pacific Lung Cancer Surgery Market, 2025 & 2035
Fig 17. Latin America Lung Cancer Surgery Market, 2025 & 2035
Fig 18. Middle East & Africa Lung Cancer Surgery Market, 2025 & 2035
Fig 19. Global Lung Cancer Surgery Market, Company Market Share Analysis (2025)
